皮下ドラッグデリバリーデバイスの世界市場2020-2027:製品別(プレフィルドシリンジ、ペンインジェクター、ウェアラブルインジェクター)、流通経路別、地域別

◆英語タイトル:Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Pen Injectors, Wearable Injectors), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV065
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月15日
◆ページ数:96
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、皮下ドラッグデリバリーデバイスの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別市場規模(プレフィルドシリンジ、ペンインジェクター、オートインジェクター、ウェアラブルインジェクター、ニードルフリーインジェクター)、流通経路別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・皮下ドラッグデリバリーデバイスの世界市場規模:製品別(プレフィルドシリンジ、ペンインジェクター、オートインジェクター、ウェアラブルインジェクター、ニードルフリーインジェクター)
・皮下ドラッグデリバリーデバイスの世界市場規模:流通経路別(病院薬局、小売薬局、オンライン薬局)
・皮下ドラッグデリバリーデバイスの世界市場規模:地域別
・競争状況
【レポートの概要】

Subcutaneous Drug Delivery Devices Market Growth & Trends

The global subcutaneous drug delivery devices market size is expected to reach USD 46.6 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis.

In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.

Subcutaneous Drug Delivery Devices Market Report Highlights

• North America accounted for the largest revenue share in 2019 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income

• By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability

• By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices

• Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. By Product
1.1.2. By Distribution Channel
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Distribution Channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of chronic diseases
3.4.1.2. Increasing production of biologics
3.4.1.3. Increasing product innovations and approvals
3.4.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
3.4.2. Market restraint analysis
3.4.2.1. High cost of advanced delivery systems
3.4.2.2. Lack of awareness in developing countries
3.5. Subcutaneous Drug Delivery Devices Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Subcutaneous Drug Delivery Devices Market: By Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Prefilled syringes
4.1.2. Pen injectors
4.1.3. Auto-injectors
4.1.4. Wearable injectors
4.1.5. Needle-free injectors
4.2. Product Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Subcutaneous Drug Delivery Devices Market, by Product Outlook
4.4.1. Prefilled syringes
4.4.1.1. Prefilled syringes market estimates and forecast, 2016 – 2027 (USD Million)
4.4.2. Pen injectors
4.4.2.1. Pen injectors market estimates and forecast, 2016 – 2027(USD Million)
4.4.3. Auto injectors
4.4.3.1. Auto injectors market estimates and forecast, 2016 – 2027 (USD Million)
4.4.4. Wearable injectors
4.4.4.1. Wearable injectors market estimates and forecast, 2016 – 2027 (USD Million)
4.4.5. Needle-free injectors
4.4.5.1. Needle-free injectors market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 5. Subcutaneous Drug Delivery Devices Market: By Distribution Channel Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospital pharmacies
5.1.2. Retail pharmacies
5.1.3. Online pharmacies
5.2. By Distribution Channel Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook
5.4.1. Hospital pharmacies
5.4.1.1. Hospital pharmacies market estimates and forecast, 2016 – 2027 (USD Million)
5.4.2. Retail pharmacies
5.4.2.1. Retail pharmacies market estimates and forecast, 2016 – 2027 (USD Million)
5.4.3. Online pharmacies
5.4.3.1. Online pharmacies market estimates and forecast, 2016 – 2027(USD Million)
Chapter 6. Subcutaneous Drug Delivery Devices Market: Country Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2019 & 2027
6.2. County Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2019
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.7.2. The U.S.
6.7.2.1. U.S. market estimates and forecast, 2016 – 2027 (USD Million)
6.7.3. Canada
6.7.3.1. Canada market estimates and forecast, 2016 – 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.8.2. The U.K.
6.8.2.1. U.K. market estimates and forecast, 2016 – 2027 (USD Million)
6.8.3. Germany
6.8.3.1. Germany market estimates and forecast, 2016 – 2027 (USD Million)
6.8.4. France
6.8.4.1. France market estimates and forecast, 2016 – 2027 (USD Million)
6.8.5. Italy
6.8.5.1. Italy market estimates and forecast, 2016 – 2027 (USD Million)
6.8.6. Spain
6.8.6.1. Spain market estimates and forecast, 2016 – 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.9.2. Japan
6.9.2.1. Japan market estimates and forecast, 2016 – 2027 (USD Million)
6.9.3. China
6.9.3.1. China market estimates and forecast, 2016 – 2027 (USD Million)
6.9.4. India
6.9.4.1. India market estimates and forecast, 2016 – 2027 (USD Million)
6.9.5. South Korea
6.9.5.1. South Korea market estimates and forecast, 2016 – 2027 (USD Million)
6.9.6. Australia
6.9.6.1. Australia market estimates and forecast, 2016 – 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.10.2. Brazil
6.10.2.1. Brazil market estimates and forecast, 2016 – 2027 (USD Million)
6.10.3. Mexico
6.10.3.1. Mexico market estimates and forecast, 2016 – 2027 (USD Million)
6.10.4. Argentina
6.10.4.1. Argentina market estimates and forecast, 2016 – 2027 (USD Million)
6.10.5. Colombia
6.10.5.1. Colombia market estimates and forecast, 2016 – 2027 (USD Million)
6.11. Middle East & Africa
6.11.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.11.2. South Africa
6.11.2.1. South Africa market estimates and forecast, 2016 – 2027 (USD Million)
6.11.3. Saudi Arabia
6.11.3.1. Saudi Arabia market estimates and forecast, 2016 – 2027 (USD Million)
6.11.4. UAE
6.11.4.1. UAE market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.3.4. Gerresheimer AG
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Medtronic Plc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Ypsomed AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Elcam Medical Group
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Novo Nordisk
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Insulet Corporation
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Becton, Dickinson and Company
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. West Pharmaceutical Services, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. PharmaJet
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Inolife Sciences
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Unilife Corporation
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 3 North America subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 4 North America subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 5 The U.S. subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 6 The U.S. subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 7 Canada subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 8 Canada subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 9 Europe subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 10 Europe subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 11 Europe subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 12 The U.K. subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 13 The U.K. subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 14 Germany subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 15 Germany subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 16 Italy subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 17 Italy subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 18 Spain subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 19 Spain subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 20 France subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 21 France subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 22 Asia Pacific subcutaneous drug delivery devices market, by region, (USD Million) 2016 - 2027
Table 23 Asia Pacific subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 24 Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 25 Japan subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 26 Japan subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 27 Japan others subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 28 China subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 29 China subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 30 India subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 31 India subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 32 South Korea subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 33 South Korea subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 34 Australia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 35 Australia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 36 Latin America subcutaneous drug delivery devices market, by region, 2016 - 2027 (USD Million)
Table 37 Latin America subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 38 Latin America subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 39 Brazil subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 40 Brazil subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 41 Mexico subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 42 Mexico subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 43 Argentina subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 44 Argentina subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 45 Colombia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 46 Colombia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 47 Middle East and Africa subcutaneous drug delivery devices market, by region, 2016 - 2027 (USD Million)
Table 48 Middle East and Africa subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 49 Middle East and Africa subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 50 South Africa subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 51 South Africa subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 52 Saudi Arabia subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 53 Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)
Table 54 UAE subcutaneous drug delivery devices market, by product, 2016 - 2027 (USD Million)
Table 55 UAE subcutaneous drug delivery devices market, by distribution channel, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Subcutaneous drug delivery devices market: Market outlook
Fig. 14 Subcutaneous drug delivery devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Subcutaneous drug delivery devices market driver impact
Fig. 20 Subcutaneous drug delivery devices market restraint impact
Fig. 21 Subcutaneous drug delivery devices market strategic initiatives analysis
Fig. 22 Subcutaneous drug delivery devices market: Product movement analysis
Fig. 23 Subcutaneous drug delivery devices market: Product outlook and key takeaways
Fig. 24 Prefilled syringes market estimates and forecast, 2016 - 2027
Fig. 25 Pen injectors market estimates and forecast, 2016 - 2027
Fig. 26 Autoinjectors market estimates and forecast, 2016 - 2027
Fig. 27 Wearable injectors market estimates and forecast, 2016 - 2027
Fig. 28 Needle-free injectors market estimates and forecast, 2016 - 2027
Fig. 29 Subcutaneous drug delivery devices market: Distribution channel movement analysis
Fig. 30 Subcutaneous drug delivery devices market: Distribution channel outlook and key takeaways
Fig. 31 Hospital pharmacies market estimates and forecast, 2016 - 2027
Fig. 32 Retail pharmacies estimates and forecast, 2016 - 2027
Fig. 33 Specialty pharmacies estimates and forecast, 2016 - 2027
Fig. 34 Global subcutaneous drug delivery devices market: Regional movement analysis
Fig. 35 Global subcutaneous drug delivery devices market: Regional outlook and key takeaways
Fig. 36 Global market share and leading players
Fig. 37 North America market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Asia Pacific market share and leading players
Fig. 40 Latin America market share and leading players
Fig. 41 Middle East & Africa market share and leading players
Fig. 42 North America: SWOT
Fig. 43 Europe SWOT
Fig. 44 Asia Pacific SWOT
Fig. 45 Latin America SWOT
Fig. 46 MEA SWOT
Fig. 47 North America, by country
Fig. 48 North America
Fig. 49 North America market estimates and forecast, 2016 - 2027
Fig. 50 The U.S.
Fig. 51 The U.S. market estimates and forecast, 2016 - 2027
Fig. 52 Canada
Fig. 53 Canada market estimates and forecast, 2016 - 2027
Fig. 54 Europe
Fig. 55 Europe market estimates and forecast, 2016 - 2027
Fig. 56 The U.K.
Fig. 57 The U.K. market estimates and forecast, 2016 - 2027
Fig. 58 Germany
Fig. 59 Germany market estimates and forecast, 2016 - 2027
Fig. 60 France
Fig. 61 France market estimates and forecast, 2016 - 2027
Fig. 62 Italy
Fig. 63 Italy market estimates and forecast, 2016 - 2027
Fig. 64 Spain
Fig. 65 Spain market estimates and forecast, 2016 - 2027
Fig. 66 Asia Pacific
Fig. 67 Asia Pacific market estimates and forecast, 2016 - 2027
Fig. 68 China
Fig. 69 China market estimates and forecast, 2016 - 2027
Fig. 70 Japan
Fig. 71 Japan market estimates and forecast, 2016 - 2027
Fig. 72 India
Fig. 73 India market estimates and forecast, 2016 - 2027
Fig. 74 Australia
Fig. 75 Australia market estimates and forecast, 2016 - 2027
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecast, 2016 - 2027
Fig. 78 Latin America
Fig. 79 Latin America market estimates and forecast, 2016 - 2027
Fig. 80 Brazil
Fig. 81 Brazil market estimates and forecast, 2016 - 2027
Fig. 82 Mexico
Fig. 83 Mexico market estimates and forecast, 2016 - 2027
Fig. 84 Argentina
Fig. 85 Argentina market estimates and forecast, 2016 - 2027
Fig. 86 Colombia
Fig. 87 Colombia market estimates and forecast, 2016 - 2027
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa market estimates and forecast, 2016 - 2027
Fig. 90 South Africa
Fig. 91 South Africa market estimates and forecast, 2016 - 2027
Fig. 92 Saudi Arabia
Fig. 93 Saudi Arabia market estimates and forecast, 2016 - 2027
Fig. 94 UAE
Fig. 95 UAE market estimates and forecast, 2016 - 2027
Fig. 96 Participant Categorization- Subcutaneous Drug Delivery Devices market
Fig. 97 Market share of key market players- Subcutaneous Drug Delivery Devices market

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[皮下ドラッグデリバリーデバイスの世界市場2020-2027:製品別(プレフィルドシリンジ、ペンインジェクター、ウェアラブルインジェクター)、流通経路別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆